Karyopharm Therapeutics
KPTI
KPTI
168 hedge funds and large institutions have $987M invested in Karyopharm Therapeutics in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 61 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
+11
Holders Change %
+7.01%
% of All Funds
2.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
32
Increased
61
Reduced
44
Closed
21
Calls
$11.2M
Puts
$7.99M
Net Calls
+$3.23M
Net Calls Change
+$273K
Top Buyers
| 1 |
Millennium Management
New York
|
+$36.1M |
| 2 |
LCM
Laurion Capital Management
New York
|
+$12.9M |
| 3 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$9.29M |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.53M |
| 5 |
Alkeon Capital Management
New York
|
+$7.76M |
Top Sellers
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$87.6M |
| 2 |
Two Sigma Investments
New York
|
-$19.3M |
| 3 |
D.E. Shaw & Co
New York
|
-$15.6M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11.6M |
| 5 |
Two Sigma Advisers
New York
|
-$10.5M |
